MK-677 in every stack: smart addition or overhyped shortcut?
Quick answer
MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone release and raises IGF-1 levels; it does not suppress testosterone, which distinguishes it mechanistically from anabolic steroids and most SARMs. Its most robust human trial data come from studies in older adults with GH deficiency or muscle wasting, not healthy athletes seeking performance enhancement. Known risks include increased appetite, fluid retention, potential insulin sensitivity impairment with prolonged use, and elevated prolactin and cortisol in some individuals.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @biaxolsupplements actually say?
The creator claims MK-677 shows up in cutting, bulking, and recovery stacks because it "boosts natural growth hormone, improves sleep and helps you recover like a machine." They also argue it's safe to stack with anything because "it doesn't suppress your tests" — meaning testosterone. The conclusion is blunt: if you're not using MK-677, you're leaving gains on the table.
That's a tight pitch for a compound that, technically, is not approved by the FDA for any indication and remains classified as an investigational drug. The creator doesn't mention that. They also don't mention water retention, appetite dysregulation, or the fact that MK-677 is on WADA's prohibited list. So let's work through what holds up and what doesn't.
Does the science back this up?
Partially. MK-677 (ibutamoren) is a ghrelin receptor agonist that genuinely does stimulate pulsatile growth hormone release and raise IGF-1. The GH-boosting mechanism is real and documented. Sleep quality improvements have research support. But "recover like a machine" is marketing language, not a clinical endpoint.
A randomized controlled trial by Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) showed MK-677 increased GH and IGF-1 in older adults but didn't translate that into dramatic body composition changes without other variables controlled. Chapman et al. (1996, Journal of Clinical Endocrinology and Metabolism) confirmed acute GH secretion responses in healthy adults. On sleep, Copinschi et al. (1997, Sleep) found MK-677 increased REM sleep duration — that part of the creator's claim has legitimate backing. However, longer-term human trials showing performance or recovery superiority over, say, adequate sleep and nutrition are thin. The compound works on its target receptor. Whether that translates to the stacking benefits being sold here is a different question.
What did they get wrong (or right)?
They got the testosterone point mostly right, and credit where it's due. Unlike anabolic steroids or SARMs such as RAD-140 or LGD-4033, MK-677 does not bind androgen receptors and does not suppress the hypothalamic-pituitary-gonadal axis. Multiple studies confirm no significant change in LH, FSH, or testosterone with MK-677 use. That claim is accurate.
Where they stumble is the framing that it's therefore "perfect to stack with anything." That logic skips over real side effect concerns. MK-677 increases cortisol and prolactin in some users (Murphy et al., 1998, Journal of Clinical Endocrinology and Metabolism). It reliably increases appetite, which is a problem in a cutting stack specifically. It causes fluid retention, can worsen insulin sensitivity with prolonged use, and in one long-term study by Blackman et al. (2002, JAMA), GH-raising interventions were associated with increased rates of edema and glucose intolerance. Telling a mass audience it stacks perfectly with anything, without flagging those considerations, is irresponsible simplification.
What should you actually know?
MK-677 is not a peptide, despite being grouped with them. It's a small-molecule, orally active ghrelin mimetic. It is not approved by the FDA, it is prohibited in competitive sport under WADA regulations, and its long-term safety data in healthy adults is limited. Anyone considering it should be doing so with physician oversight and blood work, not because a supplement brand's TikTok said it belongs in every stack.
The claim that you're "leaving gains on the table" without it is pure sales language. The actual evidence base for MK-677 improving athletic performance in healthy, well-nourished adults is not strong. Its most studied applications involve GH deficiency, muscle wasting in aging populations, and hip fracture recovery, not optimizing gym results in otherwise healthy people. There is also no compounded MK-677 equivalent to any FDA-approved drug, and the regulatory status of oral MK-677 sold as a supplement is legally ambiguous at best.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 11 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 in every stack: smart addition or overhyped shortcut?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
MK-677 in every stack: smart addition or overhyped shortcut? should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone release and raises IGF-1 levels; it does not suppress testosterone, which distinguishes it mechanistically from anabolic steroids and most SARMs.
FormBlends verdict
MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone release and raises IGF-1 levels; it does not suppress testosterone, which distinguishes it mechanistically from anabolic steroids and most SARMs. Its most robust human trial data come from studies in older adults with GH deficiency or muscle wasting, not healthy athletes seeking performance enhancement. Known risks include increased appetite, fluid retention, potential insulin sensitivity impairment with prolonged use, and elevated prolactin and cortisol in some individuals.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is an oral ghrelin receptor agonist that stimulates endogenous growth hormone release and raises IGF-1 levels; it does not suppress testosterone, which distinguishes it mechanistically from anabolic steroids and most SARMs. Its most robust human trial data come from studies in older adults with GH deficiency or muscle wasting, not healthy athletes seeking performance enhancement. Known risks include increased appetite, fluid retention, potential insulin sensitivity impairment with prolonged use, and elevated prolactin and cortisol in some individuals.
- MK-677 is not an approved drug and is prohibited under WADA regulations, meaning competitive athletes risk sanctions if they use it.
- Copinschi et al. (1997) found increased REM sleep with MK-677 use, which is one of the more consistently supported benefits in the literature.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 is not an approved drug and is prohibited under WADA regulations, meaning competitive athletes risk sanctions if they use it.
- Copinschi et al. (1997) found increased REM sleep with MK-677 use, which is one of the more consistently supported benefits in the literature.
- MK-677 does not suppress testosterone or LH/FSH, unlike anabolic steroids or most SARMs, and that distinction is real and scientifically valid.
- Prolonged use carries documented risks including fluid retention, elevated appetite, increased cortisol and prolactin, and potential insulin sensitivity changes.
- The compound's clinical trial data is strongest in older adults with GH deficiency or wasting conditions, not healthy adults optimizing athletic performance.
- Selling MK-677 as appropriate for 'any stack' without flagging its metabolic and endocrine side effects is a significant omission that audiences deserve to know.
- Anyone considering MK-677 should consult a licensed physician and get baseline blood work, including fasting glucose, IGF-1, and a hormone panel, before use.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Biaxol Supplements EU · TikTok creator
199.2K views on this video
Mk-677 in all stacks?#biaxol #supplements #fyp #mk677
Sources & references
- [1]Nass et al. (2008)
- [2]Chapman et al. (1996)
- [3]Copinschi et al. (1997)
- [4]Murphy et al., 1998
- [5]Blackman et al. (2002)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Biaxol Supplements EU, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.